NCT05863676View on ClinicalTrials.gov

Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy

Active, not recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

July 31, 2030

Study Completion Date

July 31, 2030

Conditions
Gender DysphoriaTransgender
Interventions
PROCEDURE

Oophorectomy

Ovary will be removed for fertility preservation.

DIAGNOSTIC_TEST

Infectious Disease Testing

Infectious Disease Testing will be done on participants.

Trial Locations (1)

15213

Magee-Womens Hospital, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER